首页|Medical University of Sofia Reports Findings in Artificial Intelligence (Artific ial intelligence as a tool in drug discovery and development)
Medical University of Sofia Reports Findings in Artificial Intelligence (Artific ial intelligence as a tool in drug discovery and development)
扫码查看
点击上方二维码区域，可以放大扫码查看
原文链接
NETL
NSTL
New research on Artificial Intelligenc e is the subject of a report. According to news reporting originating in Sofia, Bulgaria, by NewsRx journalists, research stated, "The rapidly advancing field o f artificial intelligence (AI) has garnered substantial attention for its potent ial application in drug discovery and development. This opinion review criticall y examined the feasibility and prospects of integrating AI as a transformative t ool in the pharmaceutical industry." The news reporters obtained a quote from the research from the Medical Universit y of Sofia, "AI, encompassing machine learning algorithms, deep learning, and da ta analytics, offers unprecedented opportunities to streamline and enhance vario us stages of drug development. This opinion review delved into the current lands cape of AI-driven approaches, discussing their utilization in target identificat ion, lead optimization, and predictive modeling of pharmacokinetics and toxicity . We aimed to scrutinize the integration of large-scale omics data, electronic h ealth records, and chemical informatics, highlighting the power of AI in uncover ing novel therapeutic targets and accelerating drug repurposing strategies. Desp ite the considerable potential of AI, the review also addressed inherent challen ges, including data privacy concerns, interpretability of AI models, and the nee d for robust validation in real-world clinical settings. Additionally, we explor ed ethical considerations surrounding AI-driven decision-making in drug developm ent. This opinion review provided a nuanced perspective on the transformative ro le of AI in drug discovery by discussing the existing literature and emerging tr ends, presenting critical insights and addressing potential hurdles."
SofiaBulgariaEuropeArtificial Inte lligenceDrug DevelopmentDrugs and TherapiesEmerging TechnologiesHealth a nd MedicineMachine LearningPharmaceuticals
NETL
NSTL
